PMID: 11920627Mar 29, 2002Paper

Cancer mortality in the European Union, 1988-1997: the fall may approach 80,000 deaths a year

International Journal of Cancer. Journal International Du Cancer
Fabio LeviCarlo La Vecchia

Abstract

After the peak rate of cancer mortality reached in 1988 in the European Union, steady declines were observed: 9.1% for both sexes combined over the period 1988-1997 (from 147.0 to 133.6/100,000, world standard), corresponding to the avoidance of about 80,000 deaths in 1997 (approximately 39,000 below age 65 and 41,000 above). In 1997, the total number of cancer deaths also declined, for the first time. The major determining cancers for these favorable trends were stomach (-30%), lung (-10%), intestines (-15%), breast (-10%), uterus (mainly cervix; -22%), leukemias (-10%) and, after 1995, prostate (-3%).

References

Aug 1, 1995·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·S Franceschi, C Naett
May 1, 1995·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P Boyle
Feb 19, 2000·Cancer Causes & Control : CCC·B F HankeyB K Edwards
Mar 11, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J Cuzick
Jun 1, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R McKean-CowdinB E Henderson
Aug 23, 2000·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·C La VecchiaE Negri
Aug 24, 2000·Epidemiology·F LeviC La Vecchia
Sep 23, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F LeviC La Vecchia
Nov 9, 2000·Leukemia·F LeviC La Vecchia
Nov 15, 2000·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·C La Vecchia, S Franceschi
Jul 4, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F LeviC La Vecchia
Oct 2, 2001·CA: a Cancer Journal for Clinicians·R T GreenleeM Thun

❮ Previous
Next ❯

Citations

Nov 15, 2006·Wiener medizinische Wochenschrift·Christine Marosi
Sep 23, 2003·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·S PecorelliF Odicino
May 24, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R DziadziuszkoUNKNOWN EORTC Lung Cancer Group
Nov 7, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S SieslingUNKNOWN Working Group of The Netherlands Cancer Registry
Apr 24, 2012·Croatian Medical Journal·Iva KiracAriana Znaor
Nov 19, 2004·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·L MinelliF La Rosa
Apr 22, 2009·International Journal of Cancer. Journal International Du Cancer·Paola BertuccioCarlo La Vecchia
Apr 8, 2004·International Journal of Cancer. Journal International Du Cancer·Fabio LeviCarlo La Vecchia
Oct 5, 2006·Cancer·Barbara Deschler, Michael Lübbert
Aug 19, 2005·Mutation Research·Silvio De Flora, Lynnette R Ferguson
Nov 25, 2003·Anesthesia and Analgesia·Marc LickerJean-Marie Tschopp
Jun 1, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Silvio De FloraMarina Vercelli
Jan 28, 2003·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·C La VecchiaF Levi
Dec 14, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F LeviC La Vecchia

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Indian Journal of Pediatrics
P SharanV P Chaudhry
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
Maria Avksentyeva
Annals of Oncology : Official Journal of the European Society for Medical Oncology
S Garattini
© 2022 Meta ULC. All rights reserved